Summit Therapeutics has achieved massive market success in 2024, with a market capitalization of over $7 billion.Summit's main pipeline candidate is ivonescimab, a bispecific antibody targeting both ...
Source LinkSummit Therapeutics has achieved massive market success in 2024, with a market capitalization of over $7 billion.Summit's main pipeline candidate is ivonescimab, a bispecific antibody targeting both ...
Source Link
Comments